For what reasons should metformin be used in the management of polycystic ovary syndrome?

Journal of Endocrinological Investigation

Volumn 35, Issue 1, 2012, Pages 87-89

  Moghetti, P ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Metformin; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; METFORMIN;

ANOVULATION; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DRUG APPROVAL; DRUG INDICATION; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; META ANALYSIS (TOPIC); NOTE; OVARY POLYCYSTIC DISEASE; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW (TOPIC);

FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; POLYCYSTIC OVARY SYNDROME;

EID: 84861989089     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8195     Document Type: Note

References (18)

1. Lord JM, Flight IH, Norman RJ. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003: CD003053.
2. Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010: CD003053.
3. Legro RS, Barnhart HX, Schlaff WD, et al Cooperative Multicenter Reproductive Medicine Network. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007, 356: 551-66. (Pubitemid 46220816)
4. Rausch ME, Legro RS, Barnhart HX, et al, Reproductive Medicine Network. Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009, 94: 3458-66.
5. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod 2008, 23: 462-77;
6. Fertil Steril 2008, 89: 505-22.
7. Vause TD, Cheung AP, Sierra S, et al, Society of Obstetricians and Gynecologists of Canada. Ovulation induction in polycystic ovary syndrome. J Obstet Gynaecol Can 2010, 32: 495-502;
8. Int J Gynaecol Obstet 2010, 111: 95-100.
9. Moll E, Korevaar JC, Bossuyt PM, van der Veen F. Does adding metformin to Clomifene citrate lead to higher pregnancy rates in a subset of women with polycystic ovary syndrome? Hum Reprod 2008, 23: 1830-4. (Pubitemid 352020013)
10. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AEPCOS) Society. J Clin Endocrinol Metab 2010, 95: 2038-49.
11. Knowler WC, Barrett-Connor E, Fowler SE, et al Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346: 393-403. (Pubitemid 34437694)
12. Orchard TJ, Temprosa M, Goldberg R, et al Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005, 142: 611-9. (Pubitemid 40529957)
13. Moghetti P, Castello R, Negri C, et al. Metformin effects on dinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000, 85: 139-46. (Pubitemid 32268804)
14. Kassi E, Diamanti-Kandarakis E. The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome. J Endocrinol Invest 2008, 31: 1124-31.
15. Escobar-Morreale HF, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2011, Nov 6 [Epub ahead of print]; doi: 10.1093/humupd/dmr042
16. Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2011: CDP07506.
17. Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009, 32: 193-203;
18. Diabetologia 2009, 52: 17-30.